Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Bruce J. Kinon
JCP
Original Research
Analysis of Gene Variants Previously Associated With Iloperidone Response in Patients With Schizophrenia Who Are Treated With Risperidone
JCP
Article
New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting: A Great Opportunity for Early Career Psychiatrists
JCP
Original Research
Determinants of Antipsychotic Response in Schizophrenia: Implications for Practice and Future Clinical Trials
JCP
Article
Effective Resolution With Olanzapine of Acute Presentation of Behavioral Agitation and Positive Psychotic Symptoms in Schizophrenia
JCP
Original Research
Factors Influencing Acute Weight Change in Patients With Schizophrenia Treated With Olanzapine, Haloperidol, or Risperidone
JCP
Original Research
Long-Term Olanzapine Treatment: Weight Change and Weight-Related Health Factors in Schizophrenia
JCP
Original Research
Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response
JCP
Article
The Routine Use of Atypical Antipsychotic Agents: Maintenance Treatment
JCP
Original Research
Strategies for Switching From Conventional Antipsychotic Drugs or Risperidone to Olanzapine
JCP
Original Research
Tardive Dyskinesia and the 3-Year Course of Schizophrenia: Results From a Large, Prospective, Naturalistic Study
JCP
Article
Weight Change and Atypical Antipsychotic Treatment in Patients With Schizophrenia
